APA (7th ed.) Citation

Z, N., H, P., P, B., I, B., O, C., SC, C., . . . RD, T. (2022). IMI2-PainCare-BioPain-RCT1: Study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET). Trials, 23(1), 163. https://doi.org/10.1186/s13063-022-06087-1

Chicago Style (17th ed.) Citation

Z, Nochi, et al. "IMI2-PainCare-BioPain-RCT1: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Trial in Healthy Subjects to Investigate the Effects of Lacosamide, Pregabalin, and Tapentadol on Biomarkers of Pain Processing Observed by Peripheral Nerve Excitability Testing (NET)." Trials 23, no. 1 (2022): 163. https://doi.org/10.1186/s13063-022-06087-1.

MLA (9th ed.) Citation

Z, Nochi, et al. "IMI2-PainCare-BioPain-RCT1: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Trial in Healthy Subjects to Investigate the Effects of Lacosamide, Pregabalin, and Tapentadol on Biomarkers of Pain Processing Observed by Peripheral Nerve Excitability Testing (NET)." Trials, vol. 23, no. 1, 2022, p. 163, https://doi.org/10.1186/s13063-022-06087-1.